ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Change in the Willingness of Transplant Candidates to Accept Hepatitis C Virus Positive Deceased Donor Organs in the Era of Direct-Acting Antivirals

Q. Yuan, S. Hong, E. Roth, M. Sise, E. Bethea, W. Williams, H. Yeh, N. Elias

Transplant Center, Massachusetts General Hospital,Harvard Medical School, Boston, MA

Meeting: 2020 American Transplant Congress

Abstract number: 279

Keywords: Allocation, Donation, Graft acceptance, Infection

Session Information

Date: Saturday, May 30, 2020

Session Name: All Organs: Viral Hepatitis

Session Time: 3:15pm-4:45pm

 Presentation Time: 3:27pm-3:39pm

Location: Virtual

Related Abstracts
  • Determinants of Kidney Transplant Candidates’ Willingness to Accept Deceased Donor Organ Intervention Research: A Conjoint Analysis
  • Outcomes of Antiviral Treatment (AVT) in Hepatitis C Virus (HCV) Liver Transplant (LT) Patients off Immunosuppression (IS) in Direct Acting Antivirals (DAA) Era

*Purpose: Direct-acting antiviral (DAA) medications’ advent in 2014 very effectively changed the hepatitis C virus (HCV) treatment landscape and allowed post-transplant HCV therapy. We aimed to determine transplant candidates’ willingness to accept an HCV+ organ pre- and post-DAA.

*Methods: We conducted a retrospective cohort study based on the Organ Procurement and Transplantation Network data from 2009 to 2018. For each year, we calculated the percent candidates listed as accepting HCV antibody positive (HCV+) organ for each organ type. We used multivariable logistic regression to determine the likelihood of listed candidates accepting an HCV+ organ before and after 2014, and adjusted for candidate age, gender, ethnicity, insurance, organ failure diagnosis, comorbidity and wait times.

*Results: Over the study period, 8.6% kidney (KI), 3.8% kidney-pancreas (KP), 3.1% pancreas (PA), 12.7% heart (HR), 14.3% lung (LU), 11.7% heart-lung (HL), 29.1% liver (LI), and 8.8% intestine (IN) transplant candidates were listed as accepting HCV+ donor organs. From 2009 to 2018, the percentage accepting an HCV+ organ increased for KI, KP, HR, LU, HL; remained stable in PA and LI; and decreased for IN (Figure). On multivariate analysis, compared to pre-DAA era, willingness to accept HCV+ organs for KI candidates in the post-DAA era was 3.62 times higher (aOR 3.523.623.72), 5.75 for KP (4.545.757.28), 6.05 for HR (5.576.056.57), and 1.88 for LU (1.751.882.03). The likelihood for accepting an HCV+ PA (0.781.091.54), and HL (0.961.733.1) did not change, whereas it was lower for LI (0.730.750.77), and IN (0.020.040.09).

*Conclusions: Willingness to accept HCV+ KI, KP, HR, LU significantly increased post-DAA. Though, the willingness did not change for PA and HL, and decreased for LI and IN. HCV+ organs transplant rate and outcomes with stable or decreased candidates’ willingness warrants further investigation, to maximize organ utilization and expand the donor organ pool.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Yuan Q, Hong S, Roth E, Sise M, Bethea E, Williams W, Yeh H, Elias N. Change in the Willingness of Transplant Candidates to Accept Hepatitis C Virus Positive Deceased Donor Organs in the Era of Direct-Acting Antivirals [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/change-in-the-willingness-of-transplant-candidates-to-accept-hepatitis-c-virus-positive-deceased-donor-organs-in-the-era-of-direct-acting-antivirals/. Accessed March 3, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.